Omnicef Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global omnicef market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Omnicef is a cephalosporin antibiotic used to treat various types of infections caused by bacteria. The rise in the prevalence of urinary tract infections (UTI) is anticipated to drive the growth of the global omnicef market. For instance, according to the data published by National Center for Biotechnology Information (NCBI) in 2019, UTIs are the most common outpatient infections, with a lifetime incidence of 50.0-60.0% in women.

The prevalence of UTI increases with the age, and in women aged 65 is approximately double the rate seen in the female population overall. The prevalence in women over 65 years of age is approximately 20.0%, compared with approximately 11.0% of the population. Nearly 60.0% of adult women are projected to have UTIs at least once in their lifetime, and close to 10.0% of postmenopausal women indicate that they had a UTI in the previous year.

The rise in the prevalence of pneumonia is further anticipated to drive the growth of the global omnicef market. For instance, according to the data published by the WHO in 2021, pneumonia registered for 14.0% of all mortalities in children under 5 years old, and 740,180 mortalities occurred in children in 2019. The WHO states that pneumonia can be protected with simple interventions, and can be treated with low cost, low tech medication, and care.

The growing application area of Omnicef 200 mg tablet is anticipated to drive the growth of the market. Omnicef 200 mg is an antibacterial medication manufactured by Aristo Pharmaceutical Pvt, Ltd. The tablet is used for the treatment of typhoid fever and urinary tract infection(UTI). The tablet possesses the potential to prevent bacteria and stop their future growth.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Aurobindo Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd, and Astellas Pharma among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Omnicef Market Report by Segment

By Type

• Tablet
• Capsules

By Application

• Infections in the Lungs
• Infections in the Throat
• Infections in the Sinus
• Infections in the skin
• Infections in the Ear